Spots Global Cancer Trial Database for Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)
Official Title: A Phase II Study of Decitabine For the Front-line Treatment of Older Patients With Acute Myeloid Leukemia
Study ID: NCT00358644
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to estimate the rate of complete remission, as well as overall survival, in older patients with Acute Myeloid Leukemia (AML).
Detailed Description:
Eligibility
Minimum Age: 60 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Duarte, California, United States
, Los Angeles, California, United States
, St. Louis, Missouri, United States
Contact Details
Name: Eisai US Medical Services
Affiliation: Eisai Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
